How adults with treatment resistant depression experience their first esketamine nasal spray treatment? Preliminary results from a French qualitative study

被引：0
|
作者：
Manolios, E. [1 ,2 ,3 ]
Mathe, J. [1 ,3 ]
Sibeoni, J. [1 ,3 ,4 ]
Rotharmel, M. [5 ]
Astruc, B. [6 ]
Falissard, B. [7 ]
Mekaoui, L. [8 ]
Laurin, A. [9 ]
Gaudre-Wattinne, E. [10 ]
Dupin, J. [10 ]
Revah-Levy, A. [1 ,3 ,4 ]
机构：
[1] INSERM, ECSTRRA Team, Paris, France
[2] Hop Europeen Georges Pompidou, APHP, Serv Psychiat & Addictol Adulte & Sujet Age, Paris, France
[3] IPSEA, Paris, France
[4] CH Argenteuil, SUPADO, Argenteuil, France
[5] Univ Dept Psychiat, Ctr Excellence Therapeut, Ctr Hosp Rouvray, Rouen, France
[6] Toises Ctr Psychiat & Psychotherapie, Lausanne, Switzerland
[7] Univ Paris Saclay, CESP, INSERM U1018, Villejuif, France
[8] GHU Paris Psychiat & Neurosci, CMME, Paris, France
[9] Nantes Univ, CHU Nantes, Nantes, France
[10] Janssen Cilag, Issy Les Moulineaux, France
来源：
EUROPEAN PSYCHIATRY | 2024年 / 67卷
关键词：
D O I：
10.1192/j.eurpsy.2024.253
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0013
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [1] Barriers to Esketamine Nasal Spray Treatment Among Adults With Treatment-Resistant Depression
    Joshi, Kruti
    Liberman, Joshua N.
    Parab, Purva
    Darer, Jonathan D.
    Harding, Lisa
    JOURNAL OF CLINICAL PSYCHIATRY, 2024, 85 (02)
  • [2] Esketamine nasal spray approved for treatment-resistant depression
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (09) : 573 - 573
  • [3] Esketamine Nasal Spray (Spravato) for Treatment-Resistant Depression
    Chaplin, Steve
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1569): : 54 - 56
  • [4] Esketamine Nasal Spray Effective in Treatment-Resistant Depression
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (04): : 296 - 296
  • [5] Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression
    Reif, Andreas
    Bitter, Istvan
    Buyze, Jozefien
    Cebulla, Kerstin
    Frey, Richard
    Fu, Dong-Jing
    Ito, Tetsuro
    Kambarov, Yerkebulan
    Llorca, Pierre-Michel
    Oliveira-Maia, Albino J.
    Messer, Thomas
    Mulhern-Haughey, Siobhan
    Rive, Benoit
    von Holt, Christian
    Young, Allan H.
    Godinov, Yordan
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (14): : 1298 - 1309
  • [6] ESKALE study, a French real-world study of esketamine nasal spray for patients with treatment-resistant depression
    Ludovic, S.
    Codet, M. A.
    Rotharmel, M.
    De Maricourt, P.
    Boursicot, J.
    Wattinne, E. Gaudre
    EUROPEAN PSYCHIATRY, 2022, 65 : S270 - S271
  • [7] Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
    Doherty, Teodora
    Wajs, Ewa
    Melkote, Rama
    Miller, Janice
    Singh, Jaskaran B.
    Weber, Michael A.
    CNS DRUGS, 2020, 34 (03) : 299 - 310
  • [8] Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
    Teodora Doherty
    Ewa Wajs
    Rama Melkote
    Janice Miller
    Jaskaran B. Singh
    Michael A. Weber
    CNS Drugs, 2020, 34 : 299 - 310
  • [9] Cardiac safety of esketamine nasal spray in treatment-resistant depression: Results from the clinical development program
    Doherty, T.
    Wajs, E.
    Funck-Brentano, C.
    Weber, M. A.
    Miller, J.
    Singh, J. B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S23 - S24
  • [10] Long-Term Cognitive Outcomes of Esketamine Nasal Spray in Treatment-Resistant Depression: A Preliminary Report
    Sobreiro, Matildes de Freitas Menezes
    Silveira, Paulo Sergio Panse
    Cavenaghi, Vitor Breseghello
    da Costa, Leandro Paulino
    de Souza, Bruno Pinatti Ferreira
    Takahashi, Rachel Emy Straus
    Starek, Renato Vianna Marotta
    Siqueira, Jose Oliveira
    Fraguas, Renerio
    PHARMACEUTICALS, 2025, 18 (02)
12345